- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nodular Lymphocyte Predominant B-Cell Lymphoma
Total 3795 results
-
ADC Therapeutics S.A.CompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | Burkitt's Lymphoma | Lymphoma, Marginal ZoneUnited Kingdom, United States, Italy
-
Kunming Hope of Health HospitalWithdrawnB-cell Lymphoma | B-cell LeukemiaChina
-
AstraZenecaActive, not recruitingCalquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient InvestigationRelapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)Japan
-
Stanford UniversityNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingLymphomas | B-cell LymphomasUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
Eleah StringerBC Cancer FoundationCompletedNeoplasms | Inflammation | Lymphoma, Small Lymphocytic | Diet Habit | Intermittent Fasting | Leukemia, Lymphocytic, ChronicCanada
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
iOMEDICO AGCompletedChronic Lymphocytic Leukemia (CLL) | Non-Hodgkin's Lymphoma (NHL) | Multiple Myeloma (MM)
-
Bio-Path Holdings, Inc.RecruitingFollicular Lymphoma | Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | DLBCL | Cutaneous T-cell Lymphoma (CTCL) | Peripheral T-cell Lymphoma (PTCL)United States
-
Fred Hutchinson Cancer CenterAstraZenecaRecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMultiple Myeloma | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Hairy Cell | Lymphoma, Mantle-cellUnited States
-
Dana-Farber Cancer InstituteRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)Terminated
-
University of California, DavisNovartisCompletedMultiple Myeloma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Hodgkin Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Eli Lilly and CompanyLoxo Oncology, Inc.Active, not recruitingLymphoma, Non-Hodgkin | B-cell Lymphoma | Multiple Myeloma | Lymphoma, Mantle-Cell | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, B-cell Marginal ZoneUnited States, France, Poland, Italy
-
SecuraBioTerminatedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States, Canada
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.CompletedLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Chongqing Precision Biotech Co., LtdRecruitingLymphoma | Leukemia | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, B-CellChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingChronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Acute Lymphocytic LeukemiaUnited States
-
Mayo ClinicCompletedLymphocytic LeukemiaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)WithdrawnWaldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | B-Cell Neoplasm | Small Lymphocytic Lymphoma | Asymptomatic COVID-19 Infection Laboratory-Confirmed | Symptomatic COVID-19 Infection Laboratory-Confirmed | Chronic Lymphocytic Leukemia/Small...United States
-
Fondazione Italiana Linfomi - ETSActive, not recruitingIndolent B-Cell LymphomasFrance, Italy, Brazil, Austria, Portugal, Ukraine
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Fate TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL) | Acute Lymphoblastic Leukemia (ALL) | Non-Hodgkin's Lymphoma (NHL) | Hodgkin's Disease | Acute Myelogenous Leukemia (AML)United States
-
Zhujiang HospitalShenzhen Geno-Immune Medical InstituteWithdrawnInterleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell MalignanciesB-Cell Leukemia | B-Cell LymphomaChina
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter SyndromeUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneRecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Lymphoma, Small LymphocyticUnited States
-
M.D. Anderson Cancer CenterCelgene CorporationActive, not recruitingLymphoma | LeukemiaUnited States
-
Merck Sharp & Dohme LLCRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Richter Transformation LymphomaPoland, United States, Canada, Chile, China, Estonia, Israel, Italy, Korea, Republic of, Spain, Sweden, Turkey, Czechia, Germany, Brazil, Portugal, Ireland, Singapore, United Kingdom, Japan, Peru
-
Novartis PharmaceuticalsCompletedLymphoblastic Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous Leukemia | Acute Myelocytic Leukemia | Burkitt's Lymphoma | Mantle-cell Lymphoma | Large-cell Lymphoma | Follicular Lymphomas | High Grade LymphomasUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedFollicular Lymphoma | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Burkitt Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Myelogenous Leukemia | Mantle-Cell Lymphoma | Chronic Myelogenous Leukemia | Prolymphocytic Leukemia | Small... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterTakedaActive, not recruitingWaldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Burkitt's Lymphoma | Primary Mediastinal Large B Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Primary CNS Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B Cell LymphomaUnited States
-
Incyte CorporationActive, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Spain, France, Italy, Belgium, Germany, Austria
-
Hebei Senlang Biotechnology Inc., Ltd.Hebei Yanda Ludaopei HospitalActive, not recruitingAcute Lymphocytic LeukemiaChina
-
Genentech, Inc.Active, not recruitingLymphocytic Leukemia, Chronic | Lymphoma, Non HodgkinUnited States, Korea, Republic of, Australia, United Kingdom, Germany, Canada, Spain
-
AbbVieCompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoFondazione Italiana LinfomiRecruitingCOVID-19 | Chronic Lymphocytic Leukemia | Indolent B-Cell Non-Hodgkin LymphomaItaly
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Canada
-
BeiGeneCompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaPoland
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaCanada
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaWithdrawnFollicular Lymphoma | Acute Myeloid Leukemia | Lymphoblastic Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Acute Lymphocytic Leukemia | Mantle-Cell Lymphoma | Hematologic Malignancy | Small Lymphocytic Lymphoma | Burkitt's Lymphoma | Marginal Zone B-cell Lymphoma | Chronic Myeloproliferative... and other conditionsUnited States
-
Sana BiotechnologyRecruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Australia
-
Novartis PharmaceuticalsActive, not recruitingChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaFinland, Spain, Korea, Republic of, Israel, Japan, Germany, Singapore